What is new in topical therapy for psoriasis?

Area of Science:

• Dermatology
• Pharmacology
• Drug Delivery Systems

Background:

• Topical therapies are standard for psoriasis management, but patient adherence is often low due to factors like formulation.
• Corticosteroids and vitamin D analogues are preferred topical treatments, with combination therapy showing superior efficacy to monotherapy.

Purpose of the Study:

• To describe a novel two-compound (calcipotriol/betamethasone dipropionate) gel formulation for psoriasis.
• To evaluate the efficacy, tolerability, and patient acceptability of this new gel compared to existing treatments.

Main Methods:

• Review of phase 2 and phase 3 study data for the two-compound gel.
• Analysis of patient interviews comparing preferences for gel, cream, and ointment formulations.

Main Results:

• The calcipotriol/betamethasone dipropionate gel demonstrated superior efficacy and fewer adverse events compared to tested comparators.
• Phase 2 and 3 studies indicated a rapid onset of action for the gel formulation.
• Patient interviews revealed a preference for gel and cream formulations over ointments due to ease of use and cosmetic acceptability.

Conclusions:

• The new two-compound gel offers an effective and well-tolerated topical treatment option for psoriasis.
• Increased patient choice through the availability of this gel formulation can potentially improve treatment adherence.
• Tailoring topical psoriasis treatment to individual patient needs remains crucial for optimal outcomes.